Search
for
Sort by
Research 121–150 of 584
- Design and synthesis of potential nano-carrier for delivery of diphencyprone to hair follicle
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- Successful Treatment of Coexisting Alopecia Areata and Bullous Pemphigoid With Dupilumab: A Case Report
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- 83 Transcriptomic meta-analysis and deconvolution approaches unveil cellular dynamics in scarring and non-scarring primary lymphocytic alopecias
- 53607 Common Contact Allergens Implicated in Frontal Fibrosing Alopecia Found in Over-the-Counter Hair Growth Serums and Solutions
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis
- Under Development JAK Inhibitors for Dermatologic Diseases
- Janus kinase inhibitors for alopecia areata
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- The first 20 years of skin of color dermatology: An era of advancements in skin, hair, and nail disorders
- Upadacitinib for the Management of Alopecia Totalis and Subtotalis in Pediatric Patients: A Case Series
- Real-world evidence in alopecia areata treatment: A narrative review
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Comparison of Safety and Efficacy of Topical Mometasone 0.1% Ointment, Calcipotriol 0.005% Ointment, and Tacrolimus 0.1% Ointment in Patients with Localized Alopecia Areata: A Triple-Arm Randomized Clinical Study
- Treatments for alopecia areata: a network meta-analysis
- Phytotherapeutic Interventions using Rodent Models of Hair Loss: Current Research and Future Strategy
- Medical Therapies
- Advances in Topical Therapies for Clinically Relevant and Prevalent Forms of Alopecia
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- Alopecia Areata: An Updated Review for 2023
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
- Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures
- Extracellular vesicles from IFN-γ-primed mesenchymal stem cells repress atopic dermatitis in mice
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients